BioCentury
ARTICLE | Company News

Ilex and Millennium announce Campath review date

October 26, 2000 7:00 AM UTC

The FDA's Oncologic Drugs Advisory Committee (ODAC) will review on Dec. 14 the companies' BLA for Campath alemtuzumab humanized monoclonal antibody against CD52 to treat advanced B cell chronic lympho...